Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Agnès Fortun"'
Autor:
Vanessa Chenouard, Isabelle Leray, Laurent Tesson, Severine Remy, Alasdair Allan, Daniel Archer, Adam Caulder, Agnès Fortun, Karine Bernardeau, Yacine Cherifi, Lydia Teboul, Laurent David, Ignacio Anegon
Publikováno v:
iScience, Vol 26, Iss 4, Pp 106399- (2023)
Summary: CRISPR-Cas9 cleavage efficacy and accuracy are the main challenges gene editing faces, and they are particularly affected by the optimal formation of the ribonucleoprotein (RNP) complex. We used nano differential scanning fluorimetry, a labe
Externí odkaz:
https://doaj.org/article/3e4821e8ad1840e39504e69a7b2227d8
Autor:
Maud Charpentier, Emilie Dupré, Agnès Fortun, Floriane Briand, Mike Maillasson, Emmanuelle Com, Charles Pineau, Nathalie Labarrière, Catherine Rabu, François Lang
Publikováno v:
Molecular Oncology, Vol 16, Iss 3, Pp 594-606 (2022)
The major challenge in antigen‐specific immunotherapy of cancer is to select the most relevant tumor antigens to target. To this aim, understanding their mode of expression by tumor cells is critical. We previously identified a melanoma‐specific
Externí odkaz:
https://doaj.org/article/47dde7fe99ec46f69abe79dee27078c7
Autor:
Juliette Vaurs, Gaël Douchin, Klara Echasserieau, Romain Oger, Nicolas Jouand, Agnès Fortun, Leslie Hesnard, Mikaël Croyal, Frédéric Pecorari, Nadine Gervois, Karine Bernardeau
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Over the past two decades, there has been a great interest in the study of HLA-E-restricted αβ T cells during bacterial and viral infections, including recently SARS-CoV-2 infection. Phenotyping of these specific HLA-E-restricted T cells r
Externí odkaz:
https://doaj.org/article/890ce0d044f14d9ebfb2c8235af6b09b
Autor:
Catherine Rabu, Laurie Rangan, Laetitia Florenceau, Agnès Fortun, Maud Charpentier, Emilie Dupré, Léa Paolini, Céline Beauvillain, Estelle Dupel, Jean-Baptiste Latouche, Olivier Adotevi, Nathalie Labarrière, François Lang
Publikováno v:
OncoImmunology, Vol 8, Iss 4 (2019)
There is now a consensus that efficient peptide vaccination against cancer requires that peptides should (i) be exclusively presented by professional APC and (ii) stimulate both CD4 and CD8-specific T cell responses. To this aim, in recent trials, pa
Externí odkaz:
https://doaj.org/article/f1026e16e4944382a2c78a43cfd2f7c5
Autor:
Emmanuelle Com, François Lang, Charles Pineau, Catherine Rabu, Nathalie Labarrière, Agnès Fortun, Emilie Dupré, Floriane Briand, Maud Charpentier, Mike Maillasson
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 16, Iss 3, Pp 594-606 (2022)
Molecular Oncology, Vol 16, Iss 3, Pp 594-606 (2022)
The major challenge in antigen‐specific immunotherapy of cancer is to select the most relevant tumor antigens to target. To this aim, understanding their mode of expression by tumor cells is critical. We previously identified a melanoma‐specific
Autor:
Laurent David, Séverine Remy, Laurent Tesson, Vanessa Chenouard, Karine Bernardeau, Agnès Fortun, Isabelle Leray, Ignacio Anegon, Yacine Cherifi
The CRISPR/Cas9 system is now the gold standard for the generation of genetically modified cell and animal models but knockin is a bottleneck. One reason could be that there is no consensus regarding the concentrations of its components to be used. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c16d6ae69e10ee946a63d1e7c8bdda2
https://doi.org/10.1101/2021.09.03.458921
https://doi.org/10.1101/2021.09.03.458921
Autor:
Agnès Fortun, Emilie Dupré, Nathalie Labarrière, Emmanuelle Com, François Lang, Charles Pineau, Floriane Briand, Catherine Rabu, Mike Maillasson, Maud Charpentier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63dfc4cbbf573bfb29f82c0b5bd48ecf
https://doi.org/10.1002/1878-0261.13088/v2/response1
https://doi.org/10.1002/1878-0261.13088/v2/response1
Autor:
François Lang, Sylvain Simon, Agnès Fortun, Amir Khammari, Virginie Vignard, Brigitte Dréno, Nicolas Jouand, Soraya Saiagh, Nathalie Labarrière, Tiffany Beauvais, Sylvain Bercegay
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2021, Online ahead of print. ⟨10.1007/s00262-021-02961-0⟩
Cancer Immunology, Immunotherapy, 2021, Online ahead of print. ⟨10.1007/s00262-021-02961-0⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2021, Online ahead of print. ⟨10.1007/s00262-021-02961-0⟩
Cancer Immunology, Immunotherapy, 2021, Online ahead of print. ⟨10.1007/s00262-021-02961-0⟩
Adoptive cell transfer (ACT) of tumor-specific T lymphocytes represents a relevant therapeutic strategy to treat metastatic melanoma patients. Ideal T-cells should combine tumor specificity and reactivity with survival in vivo, while avoiding autoimm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8593ae7b130854c47879fa356985a5
https://www.hal.inserm.fr/inserm-03260784/document
https://www.hal.inserm.fr/inserm-03260784/document
Autor:
Léa Paolini, Olivier Adotevi, Maud Charpentier, E Dupel, Agnès Fortun, Emilie Dupré, Catherine Rabu, Nathalie Labarrière, Céline Beauvillain, L. Rangan, Jean-Baptiste Latouche, François Lang, Laetitia Florenceau
Publikováno v:
OncoImmunology
OncoImmunology, Taylor & Francis, 2019, 8 (4), pp.e1560919. ⟨10.1080/2162402X.2018.1560919⟩
OncoImmunology, Taylor & Francis, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
Oncoimmunology
OncoImmunology, Vol 8, Iss 4 (2019)
OncoImmunology, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
OncoImmunology, Taylor & Francis, 2019, 8 (4), pp.e1560919. ⟨10.1080/2162402X.2018.1560919⟩
OncoImmunology, Taylor & Francis, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
Oncoimmunology
OncoImmunology, Vol 8, Iss 4 (2019)
OncoImmunology, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
International audience; There is now a consensus that efficient peptide vaccination against cancer requires that peptides should (i) be exclusively presented by professional APC and (ii) stimulate both CD4 and CD8-specific T cell responses. To this a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd5c6d1e4eb958168d0931139ddca4f
https://hal.archives-ouvertes.fr/hal-02131764/document
https://hal.archives-ouvertes.fr/hal-02131764/document
Autor:
Delphine Carbonnelle, Michel Krempf, Nathalie Labarrière, François Lang, Maud Charpentier, Laetitia Florenceau, Agnès Fortun, Mikaël Croyal, Catherine Rabu
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2016, 7, ⟨10.18632/oncotarget.10923⟩
Oncotarget, Impact journals, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget 37 (7), 59704-59713. (2016)
Oncotarget, Impact journals, 2016, 7, ⟨10.18632/oncotarget.10923⟩
Oncotarget, Impact journals, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget 37 (7), 59704-59713. (2016)
// Maud Charpentier 1 , Mikael Croyal 2, 3 , Delphine Carbonnelle 1 , Agnes Fortun 1 , Laetitia Florenceau 1, 4 , Catherine Rabu 1 , Michel Krempf 2, 3, 4 , Nathalie Labarriere 1, 4 , Francois Lang 1 1 CRCNA, INSERM, CNRS, Universite d’Angers, Univ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ab9674eccd8ff434f2cde6fbace64f
https://www.hal.inserm.fr/inserm-01409602
https://www.hal.inserm.fr/inserm-01409602